Commonwealth Equity Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$832K Sell
1,590
-752
-32% -$359K ﹤0.01% 2759
2025
Q4
$1.36M Sell
2,342
-135
-5% -$69K ﹤0.01% 2323
2025
Q3
$1.14M Buy
2,477
+630
+34% +$235K ﹤0.01% 2495
2025
Q2
$559K Buy
1,847
+18
+1% +$5.36K ﹤0.01% 3055
2025
Q1
$606K Sell
1,829
-7
-0.4% -$2.3K ﹤0.01% 2879
2024
Q4
$567K Sell
1,836
-116
-6% -$32.6K ﹤0.01% 2862
2024
Q3
$414K Sell
1,952
-116
-6% -$29.7K ﹤0.01% 3061
2024
Q2
$579K Buy
2,068
+1,114
+117% +$265K ﹤0.01% 2711
2024
Q1
$255K Buy
+954
New +$225K ﹤0.01% 3424
2015
Q4
Sell
-736
Closed -$45K 2220
2015
Q3
$45K Sell
736
-343
-32% -$24.8K ﹤0.01% 2061
2015
Q2
$84K Buy
1,079
+714
+196% +$59.9K ﹤0.01% 2097
2015
Q1
$25K Buy
+365
New +$31.3K ﹤0.01% 2148

Other funds holding MDGL